MedPath
HSA Approval

GLYCOMET TABLET 500 mg

SIN07530P

GLYCOMET TABLET 500 mg

GLYCOMET TABLET 500 mg

October 26, 1993

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BA02

metformin

Manufacturer Information

ZYFAS MEDICAL CO

USV PRIVATE LIMITED

Active Ingredients

METFORMIN HCl

500 mg

Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYCOMET TABLET 500 mg - HSA Approval | MedPath